| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 8 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71942001 | ORION CORPORATION - FINLANDA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman